Sonja Werwitzke

1.4k total citations · 1 hit paper
38 papers, 752 citations indexed

About

Sonja Werwitzke is a scholar working on Hematology, Immunology and Surgery. According to data from OpenAlex, Sonja Werwitzke has authored 38 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 11 papers in Immunology and 10 papers in Surgery. Recurrent topics in Sonja Werwitzke's work include Platelet Disorders and Treatments (20 papers), Hemophilia Treatment and Research (17 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Sonja Werwitzke is often cited by papers focused on Platelet Disorders and Treatments (20 papers), Hemophilia Treatment and Research (17 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Sonja Werwitzke collaborates with scholars based in Germany, Austria and United States. Sonja Werwitzke's co-authors include Andreas Tiede, Rüdiger E. Scharf, Arnold Ganser, Reinhold Schmidt, Torsten Witte, Ulrich Budde, Beatrijs Oortwijn, Kenji Kamino, Ulrich J. Sachs and Katja Kniesch and has published in prestigious journals such as Blood, Annals of the Rheumatic Diseases and PLoS Genetics.

In The Last Decade

Sonja Werwitzke

36 papers receiving 736 citations

Hit Papers

Prothrombotic immune thrombocytopenia after COVID-19 vacc... 2021 2026 2022 2024 2021 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sonja Werwitzke Germany 13 471 202 171 157 84 38 752
Zohra Ahmadi Australia 8 222 0.5× 183 0.9× 272 1.6× 21 0.1× 17 0.2× 17 588
Muriel Meiring South Africa 15 534 1.1× 171 0.8× 97 0.6× 60 0.4× 88 1.0× 40 735
Tohru Sakura Japan 14 380 0.8× 65 0.3× 89 0.5× 143 0.9× 6 0.1× 32 579
J B Bussel United States 13 748 1.6× 129 0.6× 249 1.5× 78 0.5× 52 0.6× 21 956
Ilya Kirgner Israel 10 119 0.3× 47 0.2× 55 0.3× 86 0.5× 17 0.2× 31 285
Mirko Di Capua Italy 11 234 0.5× 44 0.2× 30 0.2× 60 0.4× 49 0.6× 20 422
AR Giles Canada 13 715 1.5× 80 0.4× 41 0.2× 118 0.8× 23 0.3× 26 917
Irina Zaidman Israel 13 146 0.3× 51 0.3× 137 0.8× 50 0.3× 17 0.2× 47 438
V. Veit France 14 142 0.3× 68 0.3× 113 0.7× 33 0.2× 23 0.3× 40 606
Janine J. J. Hulstein Netherlands 6 252 0.5× 29 0.1× 208 1.2× 87 0.6× 33 0.4× 6 410

Countries citing papers authored by Sonja Werwitzke

Since Specialization
Citations

This map shows the geographic impact of Sonja Werwitzke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonja Werwitzke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonja Werwitzke more than expected).

Fields of papers citing papers by Sonja Werwitzke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonja Werwitzke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonja Werwitzke. The network helps show where Sonja Werwitzke may publish in the future.

Co-authorship network of co-authors of Sonja Werwitzke

This figure shows the co-authorship network connecting the top 25 collaborators of Sonja Werwitzke. A scholar is included among the top collaborators of Sonja Werwitzke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonja Werwitzke. Sonja Werwitzke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dobbelstein, Christiane, Robert Klamroth, Christina Hart, et al.. (2025). Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A. Blood Advances. 9(22). 5853–5860.
2.
Knöbl, Paul, Johannes Oldenburg, Ulrich J. Sachs, et al.. (2025). Detection of Anti-drug Antibodies in Patients with Acquired Hemophilia A: Data from the GTH-AHA-EMI Study. Hämostaseologie. 45. 1 indexed citations
3.
Tiede, Andreas, et al.. (2023). von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model. Blood Advances. 7(21). 6771–6781. 2 indexed citations
4.
Tiede, Andreas, Christina Hart, Paul Knöbl, et al.. (2023). Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study. The Lancet Haematology. 10(11). e913–e921. 28 indexed citations
5.
Gabriel, Maria M., Gerrit M. Große, Ramona Schuppner, et al.. (2022). Microembolic signal monitoring in patients with HeartMate 3 and HeartWare left ventricular assist devices: Association with antithrombotic treatment and cerebrovascular events. Artificial Organs. 47(2). 370–379. 1 indexed citations
6.
Werwitzke, Sonja, Aurélie Goyenvalle, Annemieke Aartsma‐Rus, et al.. (2020). Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B. PLoS Genetics. 16(4). e1008690–e1008690. 5 indexed citations
8.
Tiede, Andreas, et al.. (2017). CD32 inhibition and high dose of rhFVIII suppress murine FVIII-specific recall response by distinct mechanisms in vitro. Thrombosis and Haemostasis. 117(9). 1679–1687. 6 indexed citations
9.
Werwitzke, Sonja, Ulrich Geisen, Ulrike Nowak‐Göttl, et al.. (2016). Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH‐AH 01/2010 study. Journal of Thrombosis and Haemostasis. 14(5). 940–947. 42 indexed citations
10.
Scharf, Rüdiger E., Christiane Dobbelstein, Sonja Werwitzke, & Andreas Tiede. (2015). Management of acquired haemophilia A. Hämostaseologie. 35(4). 311–318. 20 indexed citations
11.
Trummer, Arne, et al.. (2015). Deletion or inhibition of Fc gamma receptor 2B (CD32) prevents FVIII-specific activation of memory B cells in vitro. Thrombosis and Haemostasis. 114(12). 1127–1135. 8 indexed citations
12.
Ramackers, Wolf, Johannes Klose, Andreas Tiede, et al.. (2015). Effect of TNF‐alpha blockade on coagulopathy and endothelial cell activation in xenoperfused porcine kidneys. Xenotransplantation. 22(4). 284–294. 9 indexed citations
13.
Petersen, Björn, D. Herrmann, Andrea Lucas‐Hahn, et al.. (2015). siRNA Mediated Knockdown of Tissue Factor Expression in Pigs for Xenotransplantation. American Journal of Transplantation. 15(5). 1407–1414. 26 indexed citations
14.
Werwitzke, Sonja, et al.. (2009). DNA analysis from stool samples: a fast and reliable method avoiding invasive sampling methods in mouse models of bleeding disorders. Laboratory Animals. 43(4). 390–393. 11 indexed citations
15.
Tiede, Andreas, Sonja Werwitzke, Beatrijs Oortwijn, et al.. (2008). Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single‐centre cohort study. Journal of Thrombosis and Haemostasis. 6(4). 569–576. 116 indexed citations
16.
Werwitzke, Sonja, Andreas Tiede, Reinhilde Jacobs, et al.. (2008). CD8α+βlow Effector T Cells in Systemic Lupus Erythematosus. Scandinavian Journal of Immunology. 67(5). 501–508. 4 indexed citations
17.
Werwitzke, Sonja, et al.. (2008). Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophilia. Haemophilia. 14(4). 736–742. 21 indexed citations
18.
Werwitzke, Sonja, P. Sondermann, Kenji Kamino, et al.. (2007). Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fcγ receptor II (CD32). Annals of the Rheumatic Diseases. 67(2). 154–161. 40 indexed citations
19.
Werwitzke, Sonja, Kenji Kamino, Torsten Matthias, et al.. (2005). Inhibition of lupus disease by anti–double‐stranded DNA antibodies of the IgM isotype in the (NZB × NZW)F1 mouse. Arthritis & Rheumatism. 52(11). 3629–3638. 69 indexed citations
20.
Witte, Torsten, Sonja Werwitzke, & Reinhold Schmidt. (2000). CMV Complications in Common Variable Immunodeficiency. Immunobiology. 202(2). 194–198. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026